Whitehawk Therapeutics (WHWK) Change in Cash (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Change in Cash of -$2.8 million for Q1 2026, down 101.4% year-over-year from $198.8 million in Q1 2025, and down 665.29% quarter-over-quarter from -$363000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Change in Cash (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Change in Cash data on file, last reported at -$2.8 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$2.8 million, down 101.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$192.8 million (down 210.97% YoY), and the FY2025 annual result was $8.8 million, up 125.82% from the prior year.
- Change in Cash retreated to -$2.8 million in Q1 2026 per WHWK's latest filing, from -$363000.0 in the prior quarter.
- Over five years, Change in Cash peaked at $198.8 million in Q1 2025 and troughed at -$107.0 million in Q3 2025.
- A 5-year average of -$6.7 million and a median of -$5.9 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash tumbled 1753.98% in 2024, then jumped 2283.08% in 2025.
- A 5-year view of Change in Cash shows it stood at -$95.8 million in 2022, then soared by 93.83% to -$5.9 million in 2023, then jumped by 68.44% to -$1.9 million in 2024, then jumped by 80.56% to -$363000.0 in 2025, then sank by 665.29% to -$2.8 million in 2026.
- Business Quant data shows WHWK's Change in Cash at -$2.8 million in Q1 2026, -$363000.0 in Q4 2025, and -$107.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | -2.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.78 Mn |
| Dec 31, 2025 | -363,000.00 |
| Sep 30, 2025 | -107.01 Mn |
| Jun 30, 2025 | -82.63 Mn |
| Mar 31, 2025 | 198.84 Mn |
| Dec 31, 2024 | -1.87 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | -12.64 Mn |
| Mar 31, 2024 | -9.11 Mn |
| Dec 31, 2023 | -5.92 Mn |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 34.12 Mn |
| Mar 31, 2023 | -4.97 Mn |
| Dec 31, 2022 | -95.80 Mn |
| Sep 30, 2022 | 16.08 Mn |
| Jun 30, 2022 | -11.05 Mn |
| Mar 31, 2022 | -19.14 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | 149.70 Mn |
| Jun 30, 2021 | -3.34 Mn |